Medicare Enrolled
Dr. Andre Kallab, M.D.
Hematology & Oncology · Gainesville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kallab from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kallab?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kallab
Dr. Andre Kallab is a hematology & oncology specialist in Gainesville, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Kallab performed 14,479 Medicare services across 2,394 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kallab received a total of $14,160 from 66 pharmaceutical and/or device companies across 573 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kallab is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 16% volume in GA
$14,160 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,479
Medicare services
Top 16% in GA for hematology & oncology
2,394
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~689 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
10,205 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,350 | $79 | $256 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
557 | $8 | $10 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
317 | $10 | $36 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
285 | $13 | $46 |
| Iron level test | 283 | $6 | $22 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
283 | $9 | $30 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
174 | $19 | $65 |
| PSA test (prostate cancer screening) | 115 | $18 | $78 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
107 | $49 | $524 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
97 | $8 | $27 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
86 | $153 | $670 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
69 | $16 | $60 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
68 | $9 | $31 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
60 | $29 | $101 |
| New patient office visit, complex (60-74 min) | 53 | $135 | $496 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
53 | $120 | $347 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
45 | $16 | $54 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $55 | $173 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
38 | $15 | $51 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
34 | $41 | $410 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
28 | $72 | $430 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
26 | $14 | $50 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
23 | $5 | $17 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
22 | $13 | $55 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
17 | $7 | $23 |
| Screening mammography An X-ray of the breast used to detect breast cancer in women who have no signs or symptoms of the disease. |
15 | $79 | $224 |
| 3D screening mammography (tomosynthesis) A screening imaging test of the breast using 3D technology to detect potential abnormalities. |
14 | $21 | $56 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
12 | $8 | $29 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,160
Total received (2018-2024)
Avg $2,023/year across 7 years
Top 23% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
573
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,219 (93.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$791 (5.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$150 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,537
2023
$2,003
2022
$2,306
2021
$2,409
2020
$1,697
2019
$1,693
2018
$1,515
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$350
PFIZER INC.
$259
Incyte Corporation
$223
GlaxoSmithKline, LLC.
$161
ABBVIE INC.
$139
Regeneron Pharmaceuticals, Inc.
$138
Exelixis Inc.
$133
AstraZeneca Pharmaceuticals LP
$129
Janssen Biotech, Inc.
$120
E.R. Squibb & Sons, L.L.C.
$106
Bayer Healthcare Pharmaceuticals Inc.
$98
BeiGene USA, Inc.
$82
Novartis Pharmaceuticals Corporation
$74
Eisai Inc.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$69
Daiichi Sankyo Inc.
$55
Gilead Sciences, Inc.
$40
SOBI, INC
$37
Adaptive Biotechnologies Corporation
$32
Astellas Pharma US Inc
$30
Tempus AI, Inc
$28
Merck Sharp & Dohme LLC
$26
ADC Therapeutics America, Inc.
$22
PUMA BIOTECHNOLOGY, INC.
$21
Lilly USA, LLC
$20
Mirati Therapeutics, Inc.
$20
Deciphera Pharmaceuticals Inc.
$19
Karyopharm Therapeutics Inc.
$18
Agios Pharmaceuticals, Inc.
$16
Top 3 companies account for 32.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,582
E.R. Squibb & Sons, L.L.C.
$1,207
Celgene Corporation
$1,008
Seagen Inc.
$905
Incyte Corporation
$561
Genentech USA, Inc.
$547
Novartis Pharmaceuticals Corporation
$506
Exelixis Inc.
$488
Janssen Biotech, Inc.
$464
Amgen Inc.
$459
GENZYME CORPORATION
$446
ABBVIE INC.
$357
GlaxoSmithKline, LLC.
$341
JAZZ PHARMACEUTICALS INC.
$331
Ipsen Biopharmaceuticals, Inc
$329
PFIZER INC.
$310
Astellas Pharma US Inc
$295
Eisai Inc.
$276
Pharmacyclics LLC, an AbbVie Company
$258
Daiichi Sankyo Inc.
$230
Bayer Healthcare Pharmaceuticals Inc.
$207
Merck Sharp & Dohme Corporation
$197
Heron Therapeutics, Inc.
$191
Pharmacyclics LLC, An AbbVie Company
$171
BeiGene USA, Inc.
$169
Lilly USA, LLC
$167
COMSORT, Inc
$150
Regeneron Pharmaceuticals, Inc.
$138
Takeda Pharmaceuticals U.S.A., Inc.
$129
Verastem, Inc.
$125
Gilead Sciences, Inc.
$109
EISAI INC.
$103
Blueprint Medicines Corporation
$93
Epizyme, Inc.,
$83
Rigel Pharmaceuticals, Inc.
$75
ADC Therapeutics America, Inc.
$60
MorphoSys, US Inc.
$60
G1 Therapeutics, Inc.
$59
ARRAY BIOPHARMA INC
$58
Coherus Biosciences Inc.
$57
TerSera Therapeutics LLC
$55
Karyopharm Therapeutics Inc.
$54
Kite Pharma, Inc.
$51
Merck Sharp & Dohme LLC
$49
Agios Pharmaceuticals, Inc.
$47
Taiho Oncology, Inc.
$47
Bayer HealthCare Pharmaceuticals Inc.
$46
Mirati Therapeutics, Inc.
$41
SOBI, INC
$37
Epizyme, Inc.
$37
PUMA BIOTECHNOLOGY, INC.
$36
Deciphera Pharmaceuticals Inc.
$34
Regeneron Healthcare Solutions, Inc.
$33
EMD Serono, Inc.
$32
Adaptive Biotechnologies Corporation
$32
Tempus AI, Inc
$28
ABIOMED
$26
Seattle Genetics, Inc.
$24
Dova Pharmaceuticals
$24
Sumitomo Pharma America, Inc.
$22
TOLMAR Pharmaceuticals, Inc.
$20
CTI BioPharma Corp.
$20
Puma Biotechnology, Inc.
$18
AVEO Pharmaceuticals, Inc.
$17
Fortovia Therapeutics, Inc.
$13
Clovis Oncology, Inc.
$13
Top 3 companies account for 26.8% of all-time payments
Associated products mentioned in payments ›
6 · ADCETRIS · AYVAKIT · BLENREP · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIGARD · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · Enhertu · FOTIVDA · FRUZAQLA · GAVRETO · GAZYVA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INREBIC · Imbruvica · Impella · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PEMAZYRE · PIQRAY · PYRUKYND · Padcev · Phesgo · Pomalyst · QINLOCK · REBLOZYL · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SUSTOL · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · Tavalisse · Tazverik · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XGEVA · XPOVIO · XTANDI · Xermelo · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
9
Per 100K population
4.3
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kallab is a mixed practice specialist, with above-average Medicare volume (top 16% in GA), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kallab experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Kallab performed 10,205 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kallab receive payments from pharmaceutical companies?
Yes. Dr. Kallab received a total of $14,160 from 66 companies across 573 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kallab's costs compare to other hematology & oncology specialists in Gainesville?
Dr. Kallab's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kallab) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Gainesville
Browse hematology & oncology specialists in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology